199730 — BioInfra Co Balance Sheet
0.000.00%
- KR₩23bn
- KR₩26bn
- KR₩24bn
Annual balance sheet for BioInfra Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7,174 | 5,782 | 7,362 | 14,694 | 11,032 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,177 | 6,840 | 5,260 | 6,608 | 3,616 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9,461 | 22,996 | 12,867 | 21,408 | 14,764 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,667 | 7,865 | 17,413 | 18,868 | 18,833 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 17,448 | 33,740 | 32,589 | 47,004 | 41,121 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11,533 | 11,154 | 6,375 | 8,485 | 9,219 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 13,127 | 22,877 | 14,680 | 13,030 | 13,553 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Total Equity | 4,322 | 10,862 | 17,910 | 33,974 | 27,568 |
| Total Liabilities & Shareholders' Equity | 17,448 | 33,740 | 32,589 | 47,004 | 41,121 |
| Total Common Shares Outstanding |